CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 44 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $73,000 | -91.6% | 34,709 | -78.3% | 0.01% | -58.3% |
| Q4 2019 | $869,000 | +133.6% | 159,773 | +29.2% | 0.02% | +166.7% |
| Q3 2019 | $372,000 | +5.1% | 123,709 | +30.6% | 0.01% | +12.5% |
| Q2 2019 | $354,000 | 0.0% | 94,696 | +7.6% | 0.01% | 0.0% |
| Q1 2019 | $354,000 | +4.1% | 88,033 | -4.9% | 0.01% | -11.1% |
| Q4 2018 | $340,000 | -38.2% | 92,601 | +44.8% | 0.01% | -18.2% |
| Q3 2018 | $550,000 | -9.4% | 63,936 | +16.2% | 0.01% | -8.3% |
| Q2 2018 | $607,000 | -1.3% | 55,034 | +3.2% | 0.01% | -7.7% |
| Q1 2018 | $615,000 | +140.2% | 53,352 | +123.9% | 0.01% | +116.7% |
| Q4 2017 | $256,000 | -10.8% | 23,829 | +72.6% | 0.01% | -14.3% |
| Q1 2017 | $287,000 | – | 13,809 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $11,661,000 | 2.42% |
| Telemetry Investments, L.L.C. | 189,081 | $673,000 | 1.14% |
| CHI Advisors LLC | 490,877 | $1,748,000 | 0.49% |
| BVF INC/IL | 1,943,712 | $6,920,000 | 0.27% |
| Orbimed Advisors | 6,767,584 | $24,093,000 | 0.21% |
| Novo Holdings A/S | 847,906 | $3,019,000 | 0.13% |
| Golden Green, Inc. | 19,539 | $70,000 | 0.06% |
| ALGERT GLOBAL LLC | 15,467 | $55,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,700 | $476,000 | 0.01% |
| Hikari Power Ltd | 19,959 | $71,000 | 0.01% |